Darzalex Faspro
daratumumab and hyaluronidase-fihj (human recombinant)
- Strength
- 1800 mg/15mL, 30000 U/15mL
- Form
- Injection
- Class
- CD38-directed Cytolytic Antibody; Endog…
Janssen Biotech, Inc.
Not stocked by us — reference only
Daratumumab
Listed by Janssen Biotech, Inc.
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Drug class | CD38-directed Cytolytic Antibody |
| Approval route | BLA — biologic licence |
| NDC code | 57894-502 |
| FDA application | BLA761036 |
| RxNorm concept | 1721951 |
| Package sizes listed | 2 |
| Marketed since | November 2015 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
daratumumab and hyaluronidase-fihj (human recombinant)
Janssen Biotech, Inc.
Not stocked by us — reference only
Daratumumab
Janssen Biotech, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.